Cognitive enhancers, also known as nootropics, are emerging as promising tools in addiction recovery. These substances aim to improve cognitive functions like memory, attention, and decision-making, which are often impaired by prolonged substance use. Medications such as modafinil, bupropion, and acetylcysteine have shown potential in reducing cravings and supporting cognitive recovery. These drugs work by modulating neurotransmitter systems, including dopamine and glutamate, to restore balance in the brain. Cognitive training programs, combined with these enhancers, further boost recovery outcomes by strengthening executive functions. While research is ongoing, the integration of cognitive enhancers offers a novel dimension to addiction treatment, improving both neurological health and quality of life.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : PIVOT: Predictive intervention for vaping using resonance modeling of oscillatory, psychological, and trigger dynamics
Aadya, Issaquah High School, United States
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GTI, United States
Title : What to do when a tragedy strikes
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Reward deficiency syndrome solution patient claims ‘dopamine homeostasis’ provided the neurological stability to begin focusing upon healing psychic fracture associated with chronic post-traumatic stress disorder dissociative multiplicity
Elizabeth Dale Gilley, The Elle Foundation, United States